Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (325K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Porter, D. C.
Right arrow Articles by Keyomarsi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porter, D. C.
Right arrow Articles by Keyomarsi, K.
Related Collections
Right arrow RNA characterisation and manipulation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2000, Vol. 28, No. 23 e101
© 2000 Oxford University Press

Novel splice variants of cyclin E with altered substrate specificity

Donald C. Porter1 and Khandan Keyomarsi1,2,*

1Division of Molecular Medicine, Wadsworth Center, Albany, NY 12201-0509, USA and 2Department of Biomedical Sciences, State University of New York, Albany, NY 12222, USA

Cyclin E, a G1 cyclin, is overexpressed and present in low molecular weight (LMW) isoforms in breast cancer cells and tumor tissues. In this study we have examined the possibility that the shortened mRNA splice variants could give rise to tumor-specific cyclin E LMW proteins. We used the Splice Capture method to identify, enumerate and isolate known spliced mRNAs and to look for previously undetected mRNA forms of cyclin E that might be translated into the LMW proteins. We show that a new splice variant of cyclin E found in tumor cells isolated by the Splice Capture strategy, named {Delta}48, activates CDK2 more robustly than full-length cyclin E when assayed from transiently transfected cells with the natural substrate GST-Rb. We also found the Splice Capture method to be superior to the conventional RNase protection assay in analyzing the cyclin E mRNA present in normal and tumor cells. Splice Capture enumerated the relative abundance of known forms of cyclin E mRNA and easily discovered new splice variants in both normal and tumor cells. We conclude that the abundance of cyclin E splice variants in cells may represent a novel form of regulation of cyclin E, and if translated they show altered substrate specificity compared to the full length form of cyclin E.

* To whom correspondence should be addressed at present address: Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 66, Houston, TX 77030, USA. Tel: +1 713 792 3424; Fax: +1 713 794 5369; Email: kkeyomar@mdanderson.org


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
G. Lu, K. A. Seta, and D. E. Millhorn
Novel Role for Cyclin-dependent Kinase 2 in Neuregulin-induced Acetylcholine Receptor {epsilon} Subunit Expression in Differentiated Myotubes
J. Biol. Chem., June 10, 2005; 280(23): 21731 - 21738.
[Abstract] [Full Text] [PDF]

Home page
 Plant CellHome page
K. Vandepoele, J. Raes, L. De Veylder, P. Rouze, S. Rombauts, and D. Inze
Genome-Wide Analysis of Core Cell Cycle Genes in Arabidopsis
PLANT CELL, April 1, 2002; 14(4): 903 - 916.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.